Fayez Sarofim & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207M | Sell |
|
|||||
|
2025
Q1 | $262M | Sell |
|
|||||
|
2024
Q4 | $319M | Buy |
|
|||||
|
2024
Q3 | $329M | Sell |
|
|||||
|
2024
Q2 | $362M | Buy |
|
|||||
|
2024
Q1 | $291M | Sell |
|
|||||
|
2023
Q4 | $303M | Sell |
|
|||||
|
2023
Q3 | $254M | Buy |
|
|||||
|
2023
Q2 | $276M | Sell |
|
|||||
|
2023
Q1 | $351M | Sell |
|
|||||
|
2022
Q4 | $381M | Sell |
|
|||||
|
2022
Q3 | $298M | Sell |
|
|||||
|
2022
Q2 | $316M | Buy |
|
|||||
|
2022
Q1 | $284M | Buy |
|
|||||
|
2021
Q4 | $265M | Buy |
|
|||||
|
2021
Q3 | $256M | Sell |
|
|||||
|
2021
Q2 | $265M | Sell |
|
|||||
|
2021
Q1 | $264M | Buy |
|
|||||
|
2020
Q4 | $272M | Buy |
|
|||||
|
2020
Q3 | $271M | Buy |
|
|||||
|
2020
Q2 | $251M | Buy |
|
|||||
|
2020
Q1 | $249M | Buy |
|
|||||
|
2019
Q4 | $285M | Buy |
|
|||||
|
2019
Q3 | $261M | Buy |
|
|||||
|
2019
Q2 | $258M | Buy |
|
|||||
|
2019
Q1 | $249M | Buy |
|
|||||
|
2018
Q4 | $227M | Buy |
|
|||||
|
2018
Q3 | $208M | Buy |
|
|||||
|
2018
Q2 | $177M | Buy |
|
|||||
|
2018
Q1 | $157M | Sell |
|
|||||
|
2017
Q4 | $164M | Sell |
|
|||||
|
2017
Q3 | $191M | Buy |
|
|||||
|
2017
Q2 | $191M | Sell |
|
|||||
|
2017
Q1 | $191M | Sell |
|
|||||
|
2016
Q4 | $182M | Sell |
|
|||||
|
2016
Q3 | $196M | Sell |
|
|||||
|
2016
Q2 | $182M | Buy |
|
|||||
|
2016
Q1 | $167M | Sell |
|
|||||
|
2015
Q4 | $168M | Sell |
|
|||||
|
2015
Q3 | $162M | Sell |
|
|||||
|
2015
Q2 | $196M | Sell |
|
|||||
|
2015
Q1 | $208M | Sell |
|
|||||
|
2014
Q4 | $253M | Sell |
|
|||||
|
2014
Q3 | $287M | Sell |
|
|||||
|
2014
Q2 | $287M | Sell |
|
|||||
|
2014
Q1 | $288M | Sell |
|
|||||
|
2013
Q4 | $259M | Buy |
|
|||||
|
2013
Q2 | $253M | Buy |
|